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Summary 
The thymus plays a critical role in establishing and maintaining 
the peripheral T-cell pool. It does so by providing a 
microenvironment within which T-cell precursors differentiate and 
undergo selection processes to create a functional population of 
major histocompatibility complex-restricted, self-tolerant T cells. 
These cells are central to adaptive immunity. Thymic T-cell 
development is influenced by locally produced soluble factors and 
cell-to-cell interactions, as well as by sympathetic noradrenergic 
and endocrine system signalling. Thymic lymphoid and non-
lymphoid cells have been shown not only to express β- and 
α1- adrenoceptors (ARs), but also to synthesize catecholamines 
(CAs). Thus, it is suggested that CAs influence T-cell 
development via both neurocrine/endocrine and autocrine/ 
paracrine action, and that they serve as immunotransmitters 
between thymocytes and nerves. CAs acting at multiple sites 
along the thymocyte developmental route affect T-cell generation 
not only numerically, but also qualitatively. Thymic CA level and 
synthesis, as well as AR expression exhibit sex steroid-mediated 
sexual dimorphism. Moreover, the influence of CAs on T-cell 
development exhibits glucocorticoid-dependent plasticity. This 
review summarizes recent findings in this field and our current 
understanding of complex and multifaceted neuroendocrine-
immune communications at thymic level.  
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Introduction 
It is well known that the brain and immune 
system, as major adaptive systems, communicate with 
each other extensively in order to maintain body 
homeostasis. This communication involves the autonomic 
nervous system, mainly its sympathetic branch, and the 
hypothalamo-pituitary-adrenal axis (Madden and Felten 
1995, Besedovsky and Del Rey 1996, Fabris et al. 1997, 
Mocchegiani et al. 2006, Haddad 2008). The key node in 
brain-immune system crosstalk is the thymus, the primary 
lymphoid organ responsible for T-cell development 
(Dardenne and Savino 1996, Fabris et al. 1997, 
Thyagarajan and Felten 2002, Mocchegiani et al. 2006). 
The thymus receives information from both the brain and 
circulating lymphocytes (Madden and Felten 1995, Fabris 
et al. 1997, Mocchegiani et al. 2006). Lymphocytes were 
suggested to act as the body’s sixth sense transmitting 
information, via the thymus or directly, to the brain about 
responses to external or internal antigenic stimuli 
(Blalock 1994).  
There is increasing evidence that immune 
system cells, including thymic lymphoid and non-
lymphoid cells, are capable of synthesizing and releasing 
not only cytokines, but also neuropeptides, 
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neurotransmitters and hormones, and expressing specific 
receptors for these agonists (Batanero et al. 1992, 
Bergquist et al. 1994, Dardenne and Savino 1996, 
Josefsson et al. 1996, Silva et al. 2006, Pilipović et al. 
2008). Thus, coexisting in the nervous, endocrine and 
immune systems, these agonists provide the universal 
language of the neuro-endocrine-immune network. This 
enables the nervous, endocrine and immune systems to 
regulate and fine-tune their functional responses, and 
consequently allow the body to adapt to changes in the 
internal and external environments. Understanding the 
functional interactions among these three systems, and 
their relevance to various physiological processes, is 
needed: (i) to recognize the mechanisms underlying the 
onset and course of many pathologic conditions related to 
immune system disturbances, such as infective, 
autoimmune/inflammatory and neoplastic diseases, and 
(ii) to envisage therapeutic strategies to counteract their 
onset and/or progress. This review is focused on 
depicting the histotopography of thymic catecholamines 
(CAs), and elucidating the putative significance of  
CA-steroid hormone interactions, in particular between 
CA and glucocorticoids (GCs), in fine-tuning T-cell 
development and consequently immune responses. 
 
Catecholamine sources in the thymus 
 
Thymic noradrenergic innervation 
The thymus receives extensive sympathetic 
innervation (Williams and Felten 1981, Felten et al. 
1985, Novotny et al. 1990, Vizi et al. 1995, Cavallotti et 
al. 1999, Nance and Sanders 2007). Thus, noradrenergic 
nerve profiles were identified not only along the 
vasculature in the subcapsular and associated septal 
regions, but also in close apposition to thymocytes and 
thymic epithelial cells (TECs) (Leposavić et al. 1992, 
Vizi et al. 1995). In the outer cortex, TECs forming the 
blood-thymus barrier are also exposed to circulating 
noradrenaline (NA). In addition, noradrenergic nerve 
profiles, including their varicose terminals, were 
observed in close proximity to mast cells, fibroblasts and 
macrophages (Novotny et al. 1990, Vizi et al. 1995). 
However, classical synapses between these nerve profiles 
and thymic cells were not detected. It was assumed that 
NA releases nonsynaptically from free nerve endings into 
a large extraneuronal space with no postjunctional 
specializations (Novotny et al. 1990, Vizi et al. 1995). 
Thus, most likely, NA diffuses a considerable distance 
before interacting with its receptors on target cells (Vizi 
and Labos 1991). It is also strongly believed that NA 
released from perivascular or connective tissue septa 
plexuses diffuses away through surrounding adventitia or 
collagenous fibrils, in a paracrine fashion, transmitting a 
signal to thymic cells (Elenkov et al. 2000). Moreover, 
nonsynaptic transmission occurs in thymic blood vessel 
walls (between varicose nerve terminals and smooth 
muscle cells), where NA is involved in the regulation of 
blood flow and lymphoid cell traffic (Elenkov et al. 
2000).  
Generally, NA is released in the thymus in 
response to axonal firing arising in the central nervous 
system. This release is subjected to presynaptic 
modulation by various endogenous ligands (e.g. NA, 
adrenaline, acetylcholine, adenosine, etc.) or different 
drugs from the circulation through various receptors (α2-
ARs, N-nicotinic, P1-purinergic and prostaglandin E 
presynaptic receptors) (Hasko et al. 1995).  
 
Thymic cells 
Much evidence gathered during the past 15 years 
indicates that, besides neuronal and endocrine cells, many 
types of immune cells synthesize and secrete CAs. By 
acting in an autocrine/paracrine manner they regulate 
many immune functions, including cellular proliferation, 
differentiation, apoptosis and cytokine production. 
(Bergquist et al. 1994, Josefsson et al. 1996, Cosentino et 
al. 2000, Jiang et al. 2006). Recently, we detected NA in 
rat thymocytes, whereas dopamine content was below the 
reliably measurable level (Leposavić et al. 2007, 2010, 
Pilipović et al. 2008). Given that tyrosine hydroxylase 
(TH), the rate limiting enzyme in CA synthesis, was 
found in these cells at both the protein (Leposavić et al. 
2007, 2010, Pilipović et al. 2008) and mRNA levels 
(Fig. 1), it seems highly conceivable that thymocytes not 
only take up NA passively from their microenvironment, 
but also synthesize it. The lack of measurable dopamine 
in thymocytes coincides with the finding that NA 
represents the major portion (57-95 %) of intracellular 
CAs in lymphocytes (Cosentino et al. 2000). A possible 
explanation for differential amount of NA and dopamine 
in lymphocytes is that, quite opposite to the rate of 
synthesis, the secretion rate of NA in lymphocyte cultures 
is lower than that of dopamine (Qiu et al. 2005). Flow 
cytometry analysis revealed TH immunostaining across 
all thymocyte subsets delineated by CD3 surface density, 
but the greatest frequency of TH-immunoreactive (ir) 
cells was registered within the most mature CD3high 
thymocyte subset (Pilipović et al. 2008). In agreement 
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with this finding, TH-ir thymocytes occurred most 
frequently on the medullary side of the cortico-medullary 
junction, although they were also present in the 
subcapsular cortex, and rarely intracortically and 
intramedullary (Pilipović et al. 2008). Furthermore, 
mRNA for phenylethanolamine N-methyltransferase, 
which converts NA to adrenaline, was also found in 
rodent thymi (Andreassi et al. 1998, Warthan et al. 2002). 
The specific cell types expressing mRNA for this enzyme 
have not yet been identified. We failed to detect 
adrenaline in rat thymocytes (Leposavić et al. 2007, 
Pilipović et al. 2008).  
In the rat thymus, morphologically diverse 
subsets of non-lymphoid cells were also shown to contain 
immunoreactive TH (Leposavić et al. 2007, Pilipović et 
al. 2008). Their distribution pattern roughly matches that 
of thymocytes, i.e. they densely populate the medullary 
side of the cortico-medullary junction, moderately the 
subcapsular cortex, but are extremely rare intracortically 
and intramedullary. Immunocytochemical staining of rat 
and human thymic sections and/or isolated TEC-enriched 
thymic stromal cell fractions showed TH expression in 
neural crest derived thymic nurse cells (Jones et al. 1998, 
Botham et al. 2001, Pilipović et al. 2008). These cells 
formed multicellular complexes with thymocytes and 
macrophages completely enclosed within their cytoplasm 
(Pezzano et al. 2001). They may be involved in 
thymocyte positive selection and early post-selection 
development, as well as clearance of thymocytes, which 
were negatively selected or dying from neglect (Pezzano 
et al. 2001). Namely, in thymic nurse cells were 
identified CD4+CD8+ double positive (DP) TCRαβlow 
thymocytes. These cells derive from CD4-CD8-TCRαβ- 
triple negative precursors following successful 
rearrangement of genes encoding α and β TCR chains, 
and successive surface expression of TCRαβ complex 
and CD4 and CD8 coreceptor molecules. To proceed 
further with development, DP TCRαβlow thymocytes are 
obliged to interact with self-peptides associated with 
major histocompatibility complex (MHC) antigens 
expressed on the surface of thymic non-lymphoid cells, 
and, most likely, on the vacuole surface surrounding 
engulfed thymocytes in thymic nurse cells (McCormack 
et al. 1991, Pezzano et al. 2001). At present, the most 
scrutinized hypothesis proposes that thymocytes 
producing a TCRαβ that binds either tightly or not bind 
to self-peptide in association with MHC antigens are 
selectively deleted (Marrack and Kappler 1988, 
McCormack et al. 1991). On the other hand, thymocytes 
producing a TCRαβ that binds self-peptide with low 
affinity are allowed to mature to CD4+ or CD8+ single 
positive (SP) cells, and are ultimately released from the 
thymus (Marrack and Kappler 1988, McCormack et al. 
1991). Immunoreactive TH was also found within some 
other types of TECs, possibly type 1 and type 5 TECs 
(Kranz et al. 1997, Anagnostou et al. 2007, Pilipović et 
al. 2008). Macrophages in the subcapsular/subtrabecular 
cortex and at the cortico-medullary junction also showed 
TH immunoreactivity (Leposavić et al. 2008).  
These findings indicate that in thymus, apart 
from the catecholaminergic nerve fibre network, there is 
cellular catecholaminergic network comprising lymphoid 
and non-lymphoid cells, whose functional significance 
still awaits full appreciation.  
 
Expression of adrenoceptors in the thymus 
 
Although the expression of both β1- and β2-ARs 
has been found in rat thymus, β2-ARs appears to be the 
major β-AR subtype in this tissue (Marchetti et al. 
1990a,b, 1994). We observed β2-AR-ir cells mainly in the 
subcapsular/subtrabecular cortex and the cortico-
medullary junction, but extremely rarely in the medulla 
(Leposavić et al. 2008, 2010). Expression of β2-ARs was 
demonstrated on both thymocytes and thymic non-
lymphoid cells, and TH was found in some of them as 
well (Leposavić et al. 2008). Compared to mature T 
lymphocytes, thymocytes expressed fewer β2-ARs per 
cell, with the exception of the most mature cells (Fuchs et 
al. 1988). This suggests that β2-AR expression on 
thymocytes is developmentally regulated. 
Using double immunocytochemical staining 
with antibodies specific for β2-AR and pan-cytokeratin, 
we found that subsets of TECs located mainly in the 
cortico-medulla exhibit β2-AR immunoreactivity 
(Leposavić et al. 2008). Apart from β2-ARs, functional 
studies demonstrated β1- ARs on TECs. In addition, it 
was shown that NA may directly inhibit TEC 
proliferation and cytokine secretion or modulate the 
efficacy of other stimuli (Kurz et al. 1997, von Patay et 
al. 1999). Macrophages in the subcapsular cortex and 
cortico-medullary junction also exhibit β2-AR 
immunoreactivity (Leposavić et al. 2008). Thus, it seems 
plausible to conclude that CAs, via β-ARs, influence  
T-cell development directly and indirectly, modulating 
their microenvironment. 
Data on the presence of α-ARs on T cells are 
rather limited (Kavelaars 2002). Both α1-AR mRNA and 
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α1-AR protein were demonstrated in human bone marrow 
cells and thymocytes and in rat thymocytes, respectively 
(Kavelaars 2002, Pešić et al. 2009, Leposavić et al. 
2010). Expression of α1-ARs in human peripheral blood 
mononuclear cells was undetectable or extremely low 
(van der Voort et al. 2000a, Kavelaars 2002). Thus, one 
may speculate that α1-AR expression is downregulated 
during lymphocyte development (Kavelaars 2002). In 
agreement with this hypothesis our data show that a 
majority of α1-AR positive thymocytes are the least 
mature CD3-cells (Pešić et al. 2009). Given that bone 
marrow cells and CD3- thymocytes are proliferating as 
well as differentiating cells, whereas peripheral blood 
mononuclear cells are mainly in a resting stage 
(Kavelaars 2002), it may be further speculated that the 
developmental changes in α1-AR expression are 
associated with cellular activity. Support for this 
assumption comes from several line of evidence. First, 
α1-AR mRNA expression is higher in Con A-activated T 
lymphocytes than in the corresponding resting 
lymphocytes (van der Voort et al. 2000b, Bao et al. 
2007). Second, the expression of α1-AR re-appears in 
secondary lymphoid organs, when lymphocytes start to 
proliferate and differentiate into effector cells (Kavelaars 
2002). In rat thymus, non-lymphoid cells located 
subcapsulary/subtrabeculary, in the cortico-medullary 
junction and rarely intramedullary also express α1-ARs 
(Pešić et al. 2009). Further characterization of these cells 
demonstrated that: i) they belong either to TECs or 
CD68-positive macrophages and ii) some of them also 
express TH (Pešić et al. 2009). Thus, it may be assumed 
that α1-ARs are involved not only in intercellular thymic 






The agonistic actions of CAs are terminated by 
their inactivation via intracellular oxidation. During this 
process they are degraded into various products including 
large quantities of reactive oxygen species and other 
cytotoxic oxidative metabolites, which induce apoptosis 
in mouse lymphocytes, and PC12 cell lines (Josefsson et 
al. 1996, Burke et al. 1998). Newly synthesized CAs that 
are stored inside the cells could also cause oxidative 
stress-mediated receptor-independent apoptosis 
(Cosentino et al. 2003). Even more importantly, a CA-
specific transporter was found on lymphocyte nuclear 
membranes (Bergquist et al. 1997, 2000). It actively 
transports CAs from the cytoplasm into the cell nucleus, 
where they can interact with nuclear steroid receptors and 
nuclear factor NF-κB influencing transcription processes 
and modulating apoptosis (Bergquist et al. 1997, 2000). 
Thus, it may be assumed that CAs may influence T-cell 
development also via non-AR mediated mechanisms. 
 
Gonadal steroid-dependent sexual dichotomy 
in thymic NA levels and AR expression 
 
Noradrenaline 
NA levels were higher in male than in female rat 
thymi (Pilipović et al. 2008). Considering that CAs are 
involved in modulating T-cell development (Rauški et al. 
2003a,b, Leposavić et al. 2006, Pešić et al. 2009), it may 
be hypothesized that sexual dimorphism in thymic 
weight, cellularity and thymocyte subset distribution 
(Leposavić et al. 1996), at least partly, reflects gender 
dichotomy in thymic NA availability. Furthermore, since 
T-cells are central to adaptive immunity, it has been 
speculated that the observed sexual difference in the 
efficiency of the immune response establishes during  
T-cell development (Kovacs and Olsen 1998, Ansar-
Ahmed et al. 1999). To elucidate mechanisms underlying 
sexual dimorphism in thymic NA level, we explored the 
density of noradrenergic nerve fibres and TH 
synthesizing thymic cells (Pilipović et al. 2008). There 
was no difference between male and female rats in the 
density of thymic noradrenergic nerve fibres (Pilipović et 
al. 2008), while the axonal NA content has not been 
measured. However, the densities of TH-ir lymphoid and 
non-lymphoid cells were greater in male than in female 
rats (Pilipović et al. 2008). In addition, TH mRNA 
(Fig. 1) and NA content (Pilipović et al. 2008) were 
greater in male than in female rat thymocytes. This agrees 
with data that in male rats nerve growth factor 
selectively and independently of neuronal proliferation 
induces synthesis of TH and dopamine β-hydroxylase 
(Thoenen and Barde 1980).  
To establish any sex steroid contribution to the 
sexually dimorphic thymic NA level, we explored the 
effects of bilateral gonadectomy in male and female rats 
on thymic NA level (Pilipović et al. 2008). This was 
performed at the age of 30 days given that: i) sexual 
dimorphism in immune response efficiency and 
frequency of immune pathology arises soon after sexual 
maturation (Blazkovec and Orsini 1976) and ii) the 
hormonal changes occurring at the time of puberty lay the 
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framework for biological differences that persist 
throughout life (Da Silva 1999). Gonadectomy 
diminished NA levels in thymi from adult rats of both 
sexes, but to a greater extent in males. Therefore, in 
gonadectomised rats we failed to measure any gender 
differences in thymic NA level (Pilipović et al. 2008). 
Irrespective of sex, the decrease in thymic NA levels in 
gonadectomised rats reflected the reduced density of both 
NA-containing fibres and cells (Pilipović et al. 2008). 
Support for these conclusions comes from data showing 
that: i) in male rats TH activity in the hypogastric 
(Melvin and Hamill 1986) and pelvic ganglion (Melvin 
and Hamill 1987) rises in parallel with plasma 
testosterone level during postnatal development (Resco et 
al. 1968), and ii) oestrous cycle-, pregnancy- and 
ovariectomy-related hormonal changes coincide with 
alterations in the TH level in the superior cervical 
ganglion of female rats (Anglin and Brooks 2003).  
 
Adrenoceptors 
We also found sexual dimorphism in β2-AR 
thymocyte surface expression (Fig. 1). Namely, although 
the β2-AR mRNA level was greater in thymocyte 
suspensions from female than male rats, the surface 
density of β2-ARs was less on female thymocytes 
reflecting the greater frequency of β2-AR bearing cells in 
their suspensions than in corresponding suspensions from 
male rats (Fig. 1). These findings are corroborated by 
autoradiographic studies showing a sexually dimorphic 
pattern of postnatal changes in density of β-ARs in rat 
thymus (Marchetti et al. 1990b). Furthermore, it was 
found that alterations in gonadal steroid level influence 
β2-AR thymocyte surface density in female (Marchetti et 
al. 1994). Moreover, β2-AR stimulated activity of 
adenylyl cyclase was also shown to be dependent on the 
sex steroid hormone background (Marchetti et al. 1994). 
Thus, it may be assumed that gonadal steroids modulate 
the catecholaminergic influence on the thymus, affecting 
both availability of NA and/or density and functionality 
of β2-ARs. On the other hand, data on the influence of 
gonadal steroids on α1-AR density and signalling capacity 
are still lacking. 
 
Catecholamine-mediated effects on T-cell 
development 
 
Role of β-adrenoceptors 
There is accumulating clinical (Galbiati et al. 
2007) and experimental evidence (Singh 1985a,b, Alaniz 
et al. 1999) suggesting a role for CAs in maintaining 
thymic size and T-cell output. To elucidate the 
mechanism underlying the influence of CAs on these 
parameters, the effects of long-lasting treatment with 
non-selective β-AR blockers on thymopoiesis were 
 
 
Fig. 1. Gender differences in thymocyte tyrosine hydroxylase (TH) and β2-adrenoceptor (β2-AR) expression. A, Gender differences in (a) 
TH mRNA expression (as determined by real time RT-PCR), (b) frequency of TH containing thymocytes and (c) mean intensity of 
fluorescence (MIF) for TH, reflecting the thymocyte TH content (as measured by flow cytometry using monoclonal antibodies against
rat TH and FITC-conjugated goat anti-mouse IgG antibody). B, Gender differences in (d) β2-AR mRNA expression (as determined by 
real time RT-PCR), (e) frequency of β2-AR bearing thymocytes and (f) MIF for β2-AR reflecting β2-AR thymocyte surface density (as 
measured by flow cytometry using policlonal antibodies against rat β2-AR and FITC-conjugated goat anti-rabbit IgG antibodies). 
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investigated (Leposavić et al. 2000, 2006, Madden and 
Felten 2001, Pešić et al. 2007). Although β-AR blockade 
did not affect overall thymic cellularity, it significantly 
influenced the T-cell development (Leposavić et al. 2000, 
2006, Madden and Felten 2001, Pešić et al. 2007). 
Thymocytes undergoing selection appeared to be 
particularly sensitive to β-AR blockade (Leposavić et al. 
2006, Pešić et al. 2007). Long-lasting treatment with 
propranolol, a non-selective beta-blocker, diminished the 
frequency of DP TCRαβlow cells entering selection 
processes. This decrease, coupled with the increased 
frequency of DP TCRαβhigh cells that had just passed 
positive selection, and their SP (CD4+CD8- and CD4-
CD8+cells) TCRαβhigh descendents, strongly suggested 
enhanced positive/reduced negative selection and 
facilitated maturation of the selected cells. This in turn 
leaded to enhanced generation (Leposavić et al. 2006, 
Pešić et al. 2007), and probably subsequent egress of 
mature T cells into the periphery. Two lines of evidence 
associated alterations in thymocyte selection following 
propranolol treatment with the increase in Thy-1 surface 
density on selectable thymocytes (Leposavić et al. 2006, 
Pešić et al. 2007). First, it was shown that exogenous 
cAMP and NA can induce a decrease in steady state 
Thy-1 mRNA levels in T-lineage cells and murine 
thymocytes (Wajeman-Chao et al. 1998), which can be 
prevented by propranolol (Wajeman-Chao et al. 1998). 
Second, exaggerated negative selection and consequently 
markedly reduced de novo production of mature SP cells 
were found in Thy-1−/− mice (Hueber et al. 1997), and 
hence Thy-1 was implicated in the regulation of TCR-
dependent thymocyte selection (Killeen 1997).  
 
α1-adrenoceptors 
Differently from long-lasting blockade of  
β-ARs, long-term treatment with urapidil, an α1-AR 
antagonist, augmented thymocyte proliferation and 
increased thymocyte yield (Plećaš-Solarović et al. 2005, 
Pešić et al. 2009, Leposavić et al. 2010). As simultaneous 
administration of NA and propranolol decreased the 
frequency of proliferating cells in rat spleen (Stevenson et 
al. 2001), a stimulatory influence of urapidil on 
thymocyte proliferation was assumed (Pešić et al. 2009, 
Leposavić et al. 2010). In addition, urapidil affected the 
thymocyte phenotype profile and increased the frequency 
of DP TCRαβ- thymocytes (Pešić et al. 2009, Leposavić 
et al. 2010). In the absence of changes in the frequency of 
precedent CD4-CD8- TCRαβ- cells, this increase was 
related to a greater density of proliferating cells in the 
outer cortex of thymi from urapidil-treated than from 
control rats. Prolonged cell proliferation at the DP 
TCRαβ- developmental stage is likely to postpone TCRα 
gene rearrangement (Xi et al. 2006), and to impede 
transition to the next DP TCRαβlow developmental stage. 
Accordingly, the diminished frequency of DP TCRαβlow 
cells following urapidil treatment was attributed to 
decelerated differentiation of DP TCRαβ- thymocytes 
(Pešić et al. 2009, Leposavić et al. 2010). The unaltered 
frequency of DP TCRhigh thymocytes (being intermediary 
cells between the DP TCRαβlow and SP TCRαβhigh 
stages), in conjunction with greater Thy-1 thymocyte 
surface density (reflecting a decline in central 
sympathetic flow caused by urapidil central action) in 
young adult rats, suggested more efficient 
positive/reduced negative thymocyte selection (Pešić et 
al. 2009). The greater Thy-1 thymocyte surface density in 
these rats, most likely, was associated with a decline in 
central sympathetic flow caused by urapidil central action 
(Pešić et al. 2009). The lack of urapidil influence on Thy-
1 expression in old rats indicated that urapidil might also 
influence the thymocyte selection via direct thymic action 
(Leposavić et al. 2010). This is fully consistent with the 
observation of Bellinger et al. (2008) that CAs acting via 
α1-ARs on TECs involved in thymocyte selection may 
affect thymopoiesis. Moreover, irrespective of age, 
urapidil influenced thymocyte lineage commitment, 
causing an increase in the frequency of CD4+CD8-
TCRαβhigh and a decrease in that of CD4-CD8+TCRαβhigh 
SP cells (Pešić et al. 2009, Leposavić et al. 2010).  
 
Catecholamine-glucocorticoid interplay in 
the modulation of T-cell development 
 
Repeated and chronic stress has an important 
role in the pathogenesis of almost all diseases related to 
immune system disturbances. Both GCs and CAs 
participate not only in regulating body functions during 
steady states, but also, often acting in concert, have a 
central role in maintaining the steady state of the internal 
milieu when it is threatened or disturbed by various 
internal or external challenges (Cunnick et al. 1990, 
Dobbs et al. 1993). Having this in mind, understanding 
their interplay in immunomodulation seems to be of 
utmost importance. 
It has been shown that thymic lymphoid and 
non-lymphoid cells produce GCs and express 
glucocorticoid receptors (Lechner et al. 2000, Qiao et al. 
2009). Furthermore, GCs have been implicated in the 
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modulation of thymocyte development (Stojić-Vukanić et 
al. 2009). Moreover, they were shown to influence CA 
biosynthesis and release (Hagerty et al. 2001) and β- and 
α1-AR gene expression (Cotecchia and De Blasi 1984). 
Based on these observations, we hypothesized that CA 
effects on thymopoiesis depend on the GC milieu 
(Pilipović et al. 2010). To test this we compared 
thymocyte development in rats adrenalectomized (Adx) 
four days before starting four-day-long propranolol 
treatment (0.4 mg/100g body weight/day, s.c.) with that 
in non-Adx propranolol-treated rats. Generally, we found 
that β-AR blockade was more efficient in Adx rats than in 
non-Adx rats (Fig. 2) (Pilipović et al. 2010). This is 
corroborated by data that simultaneous administration of 
isoproterenol and hydrocortisone produces additive 
effects on many thymic indices (Durant 1986). Compared 
with non-Adx rats, we registered a more pronounced 
increase in frequency of the most mature SP (CD4+CD8- 
and CD4-CD8+) TCRαβhigh thymocytes in Adx rats, 
which, most probably reflected more efficient 
positive/less efficient negative selection (Fig. 2). Given 
that GCs augment CA synthesis and β-AR expression 
(Cotecchia and De Blasi 1984, Hagerty et al. 2001), it 
was speculated that the alterations in thymopoiesis were 
related to diminished thymic CA availability and β-AR 
expression (Pilipović et al. 2010). However, when 
compared with non-Adx rats, propranolol caused 
unproportional increase in the frequency of the most 
mature SP cells in Adx rats (i.e. a more pronounced 
increase in the frequency of CD8+CD4- than in that of 
CD8-CD4+ SP cells) (Fig. 2). Thus, it was clear that the 
differential effect of propranolol in Adx and non-Adx rats 
could not be solely explained by the more efficient β-AR 
blockade in Adx rats (Fig. 2). Considering the effects of 
α1-AR blockade on T-cell differentiation (Pešić et al. 
2009, Leposavić et al. 2010), we supposed that more 
efficient α1-AR-mediated mechanisms in Adx rats 
contributed to this phenomenon (Fig. 2). To support this 
assumption are data that prolonged exposure of cardiac 
myocytes to NA diminishes α1-AR expression (Rokosh et 
al. 1996). Thus, in propranolol-treated Adx rats an 
increased α1-AR density, and consequently sensitivity of 
α1-AR-mediated mechanisms, reflecting diminished 
sympathetic NA outflow induced by central propranolol 
action (Mora et al. 1983) and reduced intrathymic CA 
synthesis (Hagerty et al. 2001) could be expected 
(Fig. 2).  
Taken together, these data indicate that 
catecholaminergic modulation of thymopoiesis exhibits a 
substantial degree of GC-dependent plasticity (Fig. 2). 
Fig. 2. Schematic representation of 
putative effects of β-adrenoceptor 
blockade with propranolol (0.4 mg/100g 
body weight/day, s.c.) on thymocyte 
differentiation in adult rats 
adrenalectomized four days before 
starting propranolol administration. 
Adrenalectomy, most probably, 
diminishing availability of noradrenaline 
derived from noradrenergic nerve fibres 
and thymic cells, and density of thymic 
β-adrenoceptors, augments efficiency of 
β-adrenoceptor blockade, and thereby 
increases thymocyte positive/decreased 
negative selection, and consequently 
frequency of the most mature single 
positive (SP) TCRαβhigh thymocytes. In 
addition, following propranolol 
treatment in adrenalectomized rats 
increased density of thymic α1-
adrenoceptors, and consequently 
efficiency  of α1-adrenoceptor−mediated 
mechanisms leading to the increase in 
the frequency of CD4-CD8+TCRαβhigh 
and the decrease in that of CD4+CD8-
TCRαβhigh cells is likely to occur. Thus, 
the net effect of propranolol 
administration in adrenalectomized rats 
is favoured CD8 over CD4 cell 
differentiation/maturation leading to a 
more pronounced increase in frequency 
of CD4-CD8+SP TCRαβhigh compared with that of CD4+CD8-SP TCRαβhigh cells. Symbols and abbreviations:    , increase;     , decrease; 
Cap, capsule, Cx, cortex; CMJ, cortico-medullary junction; M, medulla; S, interlobulary septa; DN, double negative; DP, double positive.  





The findings collected to date indicate that 
subsets of thymic lymphoid and non-lymphoid cells also 
synthesize CAs, which together with CAs delivered by 
neural and endocrine cells, act either directly or indirectly 
on thymocytes at distinct stages of maturation, and 
consequently modulate thymic T-cell output not only 
numerically, but also qualitatively. Furthermore, they 
showed that there is sexual dimorphism in both thymic 
NA level and thymocyte surface density of β2-ARs, 
which may be responsible for sexual dimorphism in many 
thymic indices. Moreover, it is clear that CA modulation 
of thymopoiesis exhibits a significant degree of GC-
dependent plasticity. At the present time, it is not clear 
what is relationship among neural, endocrine and locally 
synthesized CAs in T-cell development modulation. 
Furthermore, putative significance of sexual dimorphism 
in NA levels and AR thymic cell densities for sexual 
dimorphism in immune response should be established. 
In addition, the relationship among circulating GCs and 
locally synthesized GCs and CAs is not understood. 
Finally, further work is required to clarify the influence 
of naturally occurring or drug-induced variance in thymic 
CA action on GC-mediated modulation of T-cell 
development.  
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